Abstract

BackgroundThe removal of introns from pre-mRNA is carried out by a large macromolecular machine called the spliceosome. The peptidyl-prolyl cis/trans isomerase PPIL1 is a component of the human spliceosome and binds to the spliceosomal SKIP protein via a binding site distinct from its active site.Principal FindingsHere, we have studied the PPIL1 protein and its interaction with SKIP biochemically and by X-ray crystallography. A minimal linear binding epitope derived from the SKIP protein could be determined using a peptide array. A 36-residue region of SKIP centred on an eight-residue epitope suffices to bind PPIL1 in pull-down experiments. The crystal structure of PPIL1 in complex with the inhibitor cyclosporine A (CsA) was obtained at a resolution of 1.15 Å and exhibited two bound Cd2+ ions that enabled SAD phasing. PPIL1 residues that have previously been implicated in binding of SKIP are involved in the coordination of Cd2+ ions in the present crystal structure. Employing the present crystal structure, the determined minimal binding epitope and previously published NMR data [1], a molecular docking study was performed. In the docked model of the PPIL1·SKIP interaction, a proline residue of SKIP is buried in a hydrophobic pocket of PPIL1. This hydrophobic contact is encircled by several hydrogen bonds between the SKIP peptide and PPIL1.ConclusionWe characterized a short, linear epitope of SKIP that is sufficient to bind the PPIL1 protein. Our data indicate that this SKIP peptide could function in recruiting PPIL1 into the core of the spliceosome. We present a molecular model for the binding mode of SKIP to PPIL1 which emphasizes the versatility of cyclophilin-type PPIases to engage in additional interactions with other proteins apart from active site contacts despite their limited surface area.

Highlights

  • Peptidyl-prolyl cis/trans isomerases (PPIases, E.C. 5.1.2.8) catalyze the isomerization of peptide bonds that precede a proline residue and can thereby facilitate folding of their substrate proteins [2]

  • Our data indicate that this SKIP peptide could function in recruiting Peptidyl-prolyl isomerase like 1 (PPIL1) into the core of the spliceosome

  • We present a molecular model for the binding mode of SKIP to PPIL1 which emphasizes the versatility of cyclophilin-type PPIases to engage in additional interactions with other proteins apart from active site contacts despite their limited surface area

Read more

Summary

Introduction

Peptidyl-prolyl cis/trans isomerases (PPIases, E.C. 5.1.2.8) catalyze the isomerization of peptide bonds that precede a proline residue and can thereby facilitate folding of their substrate proteins [2]. Proteomics analyses of spliceosomes have revealed that eight cyclophilins are present in the human spliceosome (reviewed by [5] and [6]) The abundance of these enzymes in pre-mRNA splicing in humans is striking and raises the question as to their contributions to the splicing cycle. The assembly is characterized by the stepwise recruitment of small nuclear ribonucleoprotein particles (snRNPs) as well as non-snRNP proteins It is initiated by U1 snRNP binding to the 59-splice site (complex E) followed by U2 snRNP recognizing a conserved branch point sequence in the intron (complex A). A preformed U4/U6-U5 tri-snRNP is integrated, giving rise to the precatalytic complex B spliceosome, which is still inactive This particle undergoes compositional and conformational rearrangements to become catalytically competent for the first step, resulting in complex B*. The peptidyl-prolyl cis/trans isomerase PPIL1 is a component of the human spliceosome and binds to the spliceosomal SKIP protein via a binding site distinct from its active site

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.